ERBB2 and breast cancer: Extensively characterized human breast cancer cell lines (i.e., ER+ MCF-7/T-47D; HER2+ SK-BR-3; TNBC MDA-MB-231/MDA-MB-436) enable controlled interrogation of glycolysis, oxidative metabolism, and lipid pathways [46].